» Articles » PMID: 36304464

Emerging Role of LncRNAs in Osteoarthritis: An Updated Review

Overview
Journal Front Immunol
Date 2022 Oct 28
PMID 36304464
Authors
Affiliations
Soon will be listed here.
Abstract

Osteoarthritis (OA) is a prevalent joint disease, which is associated with progressive articular cartilage loss, synovial inflammation, subchondral sclerosis and meniscus injury. The molecular mechanism underlying OA pathogenesis is multifactorial. Long non-coding RNAs (lncRNAs) are non-protein coding RNAs with length more than 200 nucleotides. They have various functions such as modulating transcription and protein activity, as well as forming endogenous small interfering RNAs (siRNAs) and microRNA (miRNA) sponges. Emerging evidence suggests that lncRNAs might be involved in the pathogenesis of OA which opens up a new avenue for the development of new biomarkers and therapeutic strategies. The purpose of this review is to summarize the current clinical and basic experiments related to lncRNAs and OA with a focus on the extensively studied H19, GAS5, MALAT1, XIST and HOTAIR. The potential translational value of these lncRNAs as therapeutic targets for OA is also discussed.

Citing Articles

Bioactive Compounds and Their Chondroprotective Effects for Osteoarthritis Amelioration: A Focus on Nanotherapeutic Strategies, Epigenetic Modifications, and Gut Microbiota.

Hridayanka K, Duttaroy A, Basak S Nutrients. 2024; 16(21).

PMID: 39519419 PMC: 11547880. DOI: 10.3390/nu16213587.


Targeting Long Noncoding RNA H19 in Subchondral Bone Osteocytes and the Alleviation of Cartilage Degradation in Osteoarthritis.

Wang R, Mehrjou B, Dehghan-Banian D, Wang B, Li Q, Deng S Arthritis Rheumatol. 2024; 77(3):283-297.

PMID: 39482250 PMC: 11865692. DOI: 10.1002/art.43028.


Serum lncRNA ITGB2-AS1 and ICAM-1 as novel biomarkers for rheumatoid arthritis and osteoarthritis diagnosis.

Selim A, Elsabagh Y, El-Sawalhi M, Ismail N, Senousy M BMC Med Genomics. 2024; 17(1):247.

PMID: 39379962 PMC: 11462822. DOI: 10.1186/s12920-024-01993-6.


Exosomes-Shuttled lncRNA SNHG7 by Bone Marrow Mesenchymal Stem Cells Alleviates Osteoarthritis Through Targeting miR-485-5p/FSP1 Axis-Mediated Chondrocytes Ferroptosis and Inflammation.

Wang Y, Hu K, Liao C, Han T, Jiang F, Gao Z Tissue Eng Regen Med. 2024; 21(8):1203-1216.

PMID: 39363054 PMC: 11589043. DOI: 10.1007/s13770-024-00668-8.


LncRNA-mediated cartilage homeostasis in osteoarthritis: a narrative review.

Zhang L, Zhang H, Xie Q, Feng H, Li H, Li Z Front Med (Lausanne). 2024; 11:1326843.

PMID: 38449881 PMC: 10915071. DOI: 10.3389/fmed.2024.1326843.


References
1.
Shermane Lim Y, Xiang X, Garg M, Le M, Wong A, Wang L . The double-edged sword of H19 lncRNA: Insights into cancer therapy. Cancer Lett. 2020; 500:253-262. DOI: 10.1016/j.canlet.2020.11.006. View

2.
Wu X, Yin S, Yan L, Liu Y, Shang L, Liu J . lncRNA DLEU1 Modulates Proliferation, Inflammation, and Extracellular Matrix Degradation of Chondrocytes through Regulating miR-671-5p. J Immunol Res. 2022; 2022:1816217. PMC: 9132666. DOI: 10.1155/2022/1816217. View

3.
Gutschner T, Baas M, Diederichs S . Noncoding RNA gene silencing through genomic integration of RNA destabilizing elements using zinc finger nucleases. Genome Res. 2011; 21(11):1944-54. PMC: 3205578. DOI: 10.1101/gr.122358.111. View

4.
Xu Y, Duan L, Liu S, Yang Y, Qiao Z, Shi L . Long intergenic non-protein coding RNA 00707 regulates chondrocyte apoptosis and proliferation in osteoarthritis by serving as a sponge for microRNA-199-3p. Bioengineered. 2022; 13(4):11137-11145. PMC: 9208525. DOI: 10.1080/21655979.2022.2061287. View

5.
Budd E, Nalesso G, Mobasheri A . Extracellular genomic biomarkers of osteoarthritis. Expert Rev Mol Diagn. 2017; 18(1):55-74. DOI: 10.1080/14737159.2018.1415757. View